رجوع
مُدرج أيضًا باسم
MTHRY
OTC
نطاق اليوم
KWD 11.00
KWD 11.00
نطاق 52 أسبوعًا
KWD 9.45
KWD 15.25
حجم التداول
300
متوسط 50 يوم / 200 يوم
KWD 12.02
/
KWD 13.38
الإغلاق السابق
KWD 11.00
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.2 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 11.1 | 3.8 |
| Net Margin % | 14.2 | 3.9 |
| Rev Growth 5Y % | 13.9 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 121.569
KWD 118.566 – KWD 127.110
|
520 B | 1 |
| FY2029 |
KWD 107.855
KWD 105.191 – KWD 112.771
|
470 B | 1 |
| FY2028 |
KWD 93.040
KWD 90.742 – KWD 97.281
|
430 B | 1 |
النقاط الرئيسية
Revenue grew 13.91% annually over 5 years — strong growth
Earnings declined -10.57% over the past year
ROE of 11.09% — decent returns on equity
Debt/Equity of 0.06 — conservative balance sheet
Generating 42.75B in free cash flow
P/E of 0.18 — trading at a low valuation
النمو
Revenue Growth (5Y)
13.91%
Revenue (1Y)19.26%
Earnings (1Y)-10.57%
FCF Growth (3Y)-7.10%
الجودة
Return on Equity
11.09%
ROIC11.72%
Net Margin14.21%
Op. Margin22.10%
الأمان
Debt / Equity
0.06
Current Ratio2.96
Interest Coverage87.83
التقييم
P/E Ratio
0.18
P/B Ratio0.02
EV/EBITDA-1.64
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.26% | Revenue Growth (3Y) | 11.10% |
| Earnings Growth (1Y) | -10.57% | Earnings Growth (3Y) | -9.13% |
| Revenue Growth (5Y) | 13.91% | Earnings Growth (5Y) | 1.71% |
| Profitability | |||
| Revenue (TTM) | 284.90B | Net Income (TTM) | 40.48B |
| ROE | 11.09% | ROA | 6.96% |
| Gross Margin | 54.18% | Operating Margin | 22.10% |
| Net Margin | 14.21% | Free Cash Flow (TTM) | 42.75B |
| ROIC | 11.72% | FCF Growth (3Y) | -7.10% |
| Safety | |||
| Debt / Equity | 0.06 | Current Ratio | 2.96 |
| Interest Coverage | 87.83 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 0.18 | P/B Ratio | 0.02 |
| P/S Ratio | 0.03 | PEG Ratio | -2.24 |
| EV/EBITDA | -1.64 | Dividend Yield | 0.01% |
| Market Cap | 7.45B | Enterprise Value | -103.06B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 284.90B | 238.88B | 230.82B | 208.16B | 169.20B |
| Net Income | 40.48B | 45.27B | 49.03B | 63.85B | 37.82B |
| EPS (Diluted) | 59.60 | 66.63 | 72.17 | 93.98 | 55.68 |
| Gross Profit | 154.36B | 140.53B | 135.19B | 123.27B | 103.40B |
| Operating Income | 62.97B | 64.38B | 71.98B | 95.14B | 58.36B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 581.74B | 490.78B | 400.65B | 345.98B | 273.12B |
| Total Liabilities | 168.94B | 124.08B | 91.13B | 82.03B | 65.86B |
| Shareholders' Equity | 378.44B | 351.92B | 302.63B | 257.84B | 199.81B |
| Total Debt | 24.42B | 18.51B | 10.38B | 8.30B | 5.42B |
| Cash & Equivalents | 134.93B | 149.66B | 118.32B | 104.25B | 89.14B |
| Current Assets | 243.43B | 240.74B | 203.47B | 198.87B | 164.11B |
| Current Liabilities | 82.11B | 67.17B | 59.58B | 57.22B | 50.31B |
درجات الاستراتيجيات
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026